Results 91 to 100 of about 120,898,698 (232)

Cadaveric renal transplantation with cyclosporin-A and steroids [PDF]

open access: yes, 1983
Cyclosporin A and steroid was compared to Imuran and prednisone in a prospective, randomized study of patients undergoing primary cadaver renal transplantation.
Hakala, TR, Rosenthal, JT, Starzl, TE
core  

Is psoriasis an independent risk factor of renal disease? A nationwide retrospective cohort study from 1996 to 2010

open access: yesDermatologica Sinica, 2017
Background: Psoriasis is a chronic inflammatory disease that affects the skin, joints, and cardiovascular system. Although a potential association of end-stage renal disease (ESRD) with psoriasis has been demonstrated in patients, the potential for the ...
Sebastian Yu   +4 more
doaj   +1 more source

CP32, a novel anti‐oomycete cyclic peptide, interferes with cell‐wall deposition in Phytophthora infestans

open access: yesJournal of Integrative Plant Biology, Volume 68, Issue 11, Page 4013-4029, November 2026.
The small cyclic peptide CP32 effectively inhibits Phytophthora infestans, the causal agent of potato and tomato late blight. Combined biochemical and phenotypic analyses demonstrate that CP32 disrupts cell wall biosynthesis, a key process in pathogen infection, resulting in a marked reduction of disease symptoms in plants.
Demetrio Marcianò   +23 more
wiley   +1 more source

Treatment of thrombophlebitis of Behçet's disease with low dose cyclosporin A

open access: yes, 1999
To describe the treatment of thrombophlebitis with low dose cyclosporin A in patients with Behçet's ...
Macchioni, P   +7 more
core  

Cyclosporin-induced remission in an infant with alkylating agents-resistant nephrotic syndrome. A case report

open access: yesThe Turkish Journal of Pediatrics, 1995
The efficacy of cyclosporin-A, a potent immunosuppressive agent, has not been clearly proven in the management of childhood nephrotic syndrome. The occurrence of early relapse as the dose of cyclosporin is tapered or as soon as the drug is stopped
G G Yilmaz, A G Güven
doaj  

RIPK4 Downregulation Reduces ABCG2 Expression, Increasing BRAF-Mutated Melanoma Cell Susceptibility to Cisplatin- and Doxorubicin-Induced Apoptosis

open access: yesBiomolecules
Melanoma cells remain resistant to chemotherapy with cisplatin (CisPt) and doxorubicin (DOX). The abnormal expression of Receptor-Interacting Protein Kinase 4 (RIPK4) in certain melanomas contributes to tumour growth through the NFκB and Wnt/β-catenin ...
Bartlomiej Olajossy   +5 more
doaj   +1 more source

Effective use of cyclosporin in sarcoidosis: a treatment strategy based on computed tomography scanning.

open access: yes, 2016
Cyclosporin was used successfully in a patient with severe pulmonary sarcoidosis, a poor response and unacceptable side-effects from corticosteroid therapy.

core   +1 more source

Concurrent clarithromycin and cyclosporin A treatment [PDF]

open access: yes, 1998
Although macrolides have been associated with significant pharmacokinetic interactions, clarithromycin is considered to have a low interaction capacity. In this study, six transplant recipients treated with cyclosporin A also received
Azanza, J.R. (José Ramón)   +4 more
core  

Effect of cyclosporin A on energy coupling in pea stem mitochondria

open access: yes, 1995
Effect of cyclosporin A on energy coupling in pea stem mitochondria is studied. It is found that incubation of mitochondria with 100 nM FCCP and/or CAtr, oligomycin, CaCl2, palmitate and ADP results, after some lag phase, in a collapse of Δ/ψ generated ...
Vianello, A.   +3 more
core   +1 more source

The effect of cyclosporin and lipopolysaccharide on fibroblasts: Implications for cyclosporin-induced gingival overgrowth

open access: yes, 1992
Drug-induced gingival overgrowth is an adverse side effect associated principally with 3 different types of drugs; specifically the antiepileptic phenytoin, the calcium channel antagonist nifedipine, and the immunosuppressant cyclosporin.
Seymour G.J., Barber M.T., Savage N.W.
core   +1 more source

Home - About - Disclaimer - Privacy